ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,241,000 | +29.6% | 154,160 | 0.0% | 0.28% | +9.9% |
| Q3 2020 | $6,359,000 | +8.7% | 154,160 | +27.8% | 0.25% | +4.6% |
| Q2 2020 | $5,848,000 | +14.7% | 120,660 | 0.0% | 0.24% | -9.7% |
| Q1 2020 | $5,098,000 | +65.3% | 120,660 | +67.4% | 0.27% | +118.9% |
| Q4 2019 | $3,084,000 | -19.2% | 72,100 | -32.0% | 0.12% | -20.3% |
| Q3 2019 | $3,815,000 | -52.5% | 106,000 | -64.7% | 0.15% | -49.3% |
| Q2 2019 | $8,027,000 | -21.7% | 300,300 | -21.4% | 0.30% | -14.9% |
| Q1 2019 | $10,257,000 | +54.0% | 382,000 | -7.3% | 0.36% | +51.7% |
| Q4 2018 | $6,662,000 | -21.7% | 412,000 | +0.5% | 0.23% | -3.3% |
| Q3 2018 | $8,512,000 | +50.9% | 410,000 | +11.0% | 0.24% | +50.3% |
| Q2 2018 | $5,641,000 | -26.2% | 369,452 | +8.7% | 0.16% | -27.5% |
| Q1 2018 | $7,640,000 | -25.4% | 340,000 | 0.0% | 0.22% | -24.5% |
| Q4 2017 | $10,237,000 | -41.6% | 340,000 | -26.9% | 0.29% | -41.1% |
| Q3 2017 | $17,517,000 | +32.2% | 465,000 | -2.1% | 0.50% | +33.8% |
| Q2 2017 | $13,248,000 | +21.8% | 475,000 | +50.1% | 0.37% | +29.5% |
| Q1 2017 | $10,877,000 | +277.1% | 316,380 | +216.4% | 0.29% | +260.0% |
| Q4 2016 | $2,884,000 | – | 100,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |